World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
54
Citations
11856
World Ranking
3877
National Ranking
1777

Cara Haymaker publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Cara Haymaker sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 252 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Cara Haymaker D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Cara Haymaker sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 1958 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Cara Haymaker is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on fields related to Medicine and Biochemistry, Genetics and Molecular Biology, with significant work in Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology, and Cancer Research.

Their research topics encompass a range of areas within cancer and immunology, including:

  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Cancer Genomics and Diagnostics
  • Pancreatic and Hepatic Oncology Research
  • Immune Cell Function and Interaction
  • Cancer Research and Treatments

Cara Haymaker has contributed to numerous scientific publications. Some recent notable papers include:

  • Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial, 2021, published in Nature Medicine
  • Identification of bacteria-derived HLA-bound peptides in melanoma, 2021, published in Nature
  • Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity, 2022, published in Cancer Cell
  • Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02), 2020, published in Cancer Discovery
  • Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial, 2023, published in Nature Medicine

Their frequent co-authors include Ignacio I. Wistuba, Chantale Bernatchez, Edwin R. Parra, Boris Sepesi, and John V. Heymach.

Cara Haymaker's work appears often in publication venues such as:

  • Regular and Young Investigator Award Abstracts
  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • Journal for ImmunoTherapy of Cancer

Among the awards recorded, Cara Haymaker is recognized as a Fellow of the American Association for the Advancement of Science (AAAS), awarded in 1958.

Best Publications

  • Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

    Weiyi Peng;Jie Qing Chen;Chengwen Liu;Shruti Malu

  • Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial.

    Erminia Massarelli;William William;Faye Johnson;Merrill Kies

  • Identification of bacteria-derived HLA-bound peptides in melanoma

    Shelly Kalaora;Adi Nagler;Deborah Nejman;Michal Alon

  • Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.

    Unknown

  • Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.

    Richard Wu;Marie Andrée Forget;Jessica Chacon;Jessica Chacon;Chantale Bernatchez

  • Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues.

    Edwin R. Parra;Naohiro Uraoka;Mei Jiang;Pamela Cook

  • Bempegaldesleukin (NKTR-214) plus Nivolumab in Patients with Advanced Solid Tumors: Phase I Dose-Escalation Study of Safety, Efficacy, and Immune Activation (PIVOT-02)

    Adi Diab;Nizar M. Tannir;Salah Eddine Bentebibel;Patrick Hwu

  • A First-in-Human Study and Biomarker Analysis of NKTR-214, a Novel IL2Rβγ-Biased Cytokine, in Patients with Advanced or Metastatic Solid Tumors

    Salah Eddine Bentebibel;Michael E. Hurwitz;Chantale Bernatchez;Cara Haymaker

  • TCR Repertoire Intratumor Heterogeneity in Localized Lung Adenocarcinomas: An Association with Predicted Neoantigen Heterogeneity and Postsurgical Recurrence.

    Alexandre Reuben;Rachel Gittelman;Jianjun Gao;Jiexin Zhang

  • Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma

    Peter Bailey;David K. Chang;Marie Andreé Forget;Francis A.San Lucas

  • Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.

    Edwin R. Parra;Pamela Villalobos;Carmen Behrens;Mei Jiang

  • Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy.

    Meenu Sharma;Hiep Khong;Faisal Fa’ak;Salah Eddine Bentebibel

  • Hallmarks of Resistance to Immune-Checkpoint Inhibitors

    Unknown

  • Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer

    Y. Kudo;Y. Kudo;C. Haymaker;J. Zhang;A. Reuben

  • Genomic and immune heterogeneity are associated with differential responses to therapy in melanoma

    Alexandre Reuben;Christine N. Spencer;Peter A. Prieto;Vancheswaran Gopalakrishnan

  • RNA editing derived epitopes function as cancer antigens to elicit immune responses

    Minying Zhang;Jens Fritsche;Jason Roszik;Leila J. Williams

  • Batf is important for IL-4 expression in T follicular helper cells.

    Anupama Sahoo;Andrei Alekseev;Kentaro Tanaka;Kentaro Tanaka;Lidiya Obertas

  • Delayed maturation of an IL-12–producing dendritic cell subset explains the early Th2 bias in neonatal immunity

    Unknown

  • Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.

    Hitoshi Dejima;Xin Hu;Runzhe Chen;Jiexin Zhang

  • Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.

    L. Federico;D.J. McGrail;S.-E. Bentebibel;C. Haymaker

  • Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set

    Jason Roszik;Lauren E. Haydu;Kenneth R Hess;Junna Oba

  • FoxP3+RORγt+ T Helper Intermediates Display Suppressive Function against Autoimmune Diabetes

    Danielle M. Tartar;Amie M. VanMorlan;Xiaoxiao Wan;F. Betul Guloglu

  • PD-1 and BTLA and CD8+ T-cell “exhaustion” in cancer: “Exercising” an alternative viewpoint

    Cara Haymaker;Richard C. Wu;Chantale Bernatchez;Laszlo G. Radvanyi

  • T-cell agonists in cancer immunotherapy.

    Yeonjoo Choi;Yaoyao Shi;Cara L Haymaker;Aung Naing

Frequent Co-Authors

Chantale Bernatchez
Chantale Bernatchez The University of Texas MD Anderson Cancer Center
Patrick Hwu
Patrick Hwu The University of Texas MD Anderson Cancer Center
Ignacio I. Wistuba
Ignacio I. Wistuba The University of Texas MD Anderson Cancer Center
Adi Diab
Adi Diab The University of Texas MD Anderson Cancer Center
Don L. Gibbons
Don L. Gibbons The University of Texas MD Anderson Cancer Center
John V. Heymach
John V. Heymach The University of Texas MD Anderson Cancer Center
Laszlo Radvanyi
Laszlo Radvanyi Ontario Institute for Cancer Research
Jennifer A. Wargo
Jennifer A. Wargo The University of Texas MD Anderson Cancer Center
Jason Roszik
Jason Roszik The University of Texas MD Anderson Cancer Center
Ara A. Vaporciyan
Ara A. Vaporciyan The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to diverse healthcare and research careers. For those interested in nursing pathways, advanced clinical roles offer promising opportunities. Nurse Practitioners (NPs) specializing in acute care need specific training, and exploring acnp programs can guide you through the transition process effectively.

Accelerated programs are also available for professionals looking to fast-track their nursing qualifications. If time is a factor, consider accelerated np programs online, which provide flexible learning tailored to busy schedules.

For individuals without a nursing background, enrolling in online rn programs for non nurses in florida can be a strategic starting point. These programs help non-nurses enter the nursing profession, enabling them to build the required foundation before advancing to specialized roles related to Immunology and patient care.

Understanding compensation is also crucial when planning your healthcare career path. Salary variations exist depending on the state, experience, and specialty. For insights into earning potential, reviewing data on how much do dnps make can help you make informed career decisions tailored to your goals and location.

Best Scientists Citing Cara Haymaker

Trending Scientists

Recently Published Articles